MedTrace Logo

Impact of the Wingate Test on Post-activation Potentiation

NCT06779409 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2025-07-04

No results posted yet for this study

Summary

The goal of this trial is to see if using a maximal effort, short cycling test is better at activating muscles to improve vertical jump height compared to a maximal effort back squat. The study looks to answer three questions:

1. will the Wingate bike test create a different change in counter movement jump height compared to a back squat?
2. What is the best recovery period after each test where the counter movement jump is the highest?
3. What person-specific factors predict success of the Wingate bike test as a activation activity for the counter movement jump? Participants will visit the lab 3 times, once to give informed consent and measure their 1 repetition max (RM) back squat, and twice to perform each intervention and measure vertical jump height.

Conditions

  • Performance Enhancement
  • Muscle Activation

Interventions

OTHER

Back squat

2 sets of 3 repetitions of a back squat, set to 85% of the 1 repetition maximum weight

OTHER

Wingate test

30 second maximal effort cycling test, with resistance at 7.5% bodyweight

Sponsors & Collaborators

  • Louisiana State University Health Sciences Center Shreveport

    lead OTHER

Principal Investigators

  • Erin McCallister, DPT · Louisiana State University Health Sciences Center Shreveport

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-14
Primary Completion
2025-04-25
Completion
2025-04-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06779409 on ClinicalTrials.gov